Eradivir Launches Phase 2 Human Challenge Trial of EV25 in Healthy Adults with Influenza Infection
Eradivir, a clinical-stage biotech firm specializing in small molecule immunotherapy, has embarked on an exciting journey to revolutionize the treatment ...
